Checkpoint inhibitor immune-related adverse events: A focused review on autoantibodies and B cells as biomarkers, advancements and future possibilities.

Taylor, John; Gandhi, Aesha; Gray, Elin; Zaenker, Pauline

Taylor, John; Gandhi, Aesha; Gray, Elin; Zaenker, Pauline.

Afiliação

Taylor J; Centre for Precision Health, Edith Cowan University, Joondalup, WA, Australia.
Gandhi A; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia.
Gray E; Sir Charles Gairdner Hospital, Department of Medical Oncology, Nedlands, WA, Australia.
Zaenker P; Centre for Precision Health, Edith Cowan University, Joondalup, WA, Australia.

Front Immunol ; 13: 991433, 2022.

Article em En | MEDLINE | ID: mdl-36713389

Assuntos

Autoanticorpos; Neoplasias; Humanos; Autoanticorpos/uso terapêutico; Qualidade de Vida; Neoplasias/tratamento farmacológico; Biomarcadores

Palavras-chave

B cells; autoantibodies; blood-based biomarkers; immune checkpoint toxicities; immune related adverse events; risk prediction

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google